Impact of beverage intake on metabolic and cardiovascular health

Nutrition Reviews

Volumn 73, Issue , 2015, Pages 120-129

  Helm, Laura ^a   Macdonald, Ian A ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Cardiovascular risk; Cocoa; Flavanols; Milk tripeptides; Orange juice; Sugar sweetened beverages; Tea

Indexed keywords

SUGAR INTAKE;

ADVERSE EFFECTS; ALCOHOLIC BEVERAGE; ANIMAL; BEVERAGE; CARDIOVASCULAR DISEASES; CHEMISTRY; DIABETES MELLITUS, TYPE 2; DIET THERAPY; FEEDING BEHAVIOR; HUMAN; MILK; PLANT; SUGAR INTAKE; WEIGHT GAIN;

ALCOHOLIC BEVERAGES; ANIMALS; BEVERAGES; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DIETARY SUCROSE; FOOD HABITS; HUMANS; MILK; PLANTS; WEIGHT GAIN;

EID: 84965191669     PISSN: 00296643     EISSN: 17534887     Source Type: Journal    
DOI: 10.1093/nutrit/nuv049     Document Type: Article

References (58)

1. Peters U, Poole C, Arab L. Does tea affect cardiovascular disease? A meta-analysis. Am J Epidemiol. 2001;154:495-503.
2. Arab L, Liu W, Elashoff D. Green and black tea consumption and risk of stroke: a meta-analysis. Stroke. 2009;40:1786-1792.
3. Wang ZM, Zhou B, Wang YS, et al. Black and green tea consumption and the risk of coronary artery disease: a meta-analysis. Am J Clin Nutr. 2011;93:506-515.
4. Geleijnse JM, Launer LJ, Hofman A, et al. Tea flavonoids may protect against atherosclerosis: the Rotterdam Study. Arch Intern Med. 1999;159:2170-2174.
5. Taubert D, Roesen R, Schomig E. Effect of cocoa and tea intake on blood pressure: a meta-analysis. Arch Intern Med. 2007;167:626-634.
6. Hooper L, Kroon PA, Rimm EB, et al. Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2008;88:38-50.
7. Zheng XX, Xu YL, Li SH, et al. Green tea intake lowers fasting serum total and LDL cholesterol in adults: a meta-analysis of 14 randomized controlled trials. Am J Clin Nutr. 2011;94:601-610.
8. Ras RT, Zock PL, Draijer R. Tea consumption enhances endothelial-dependent va-sodilation; a meta-analysis. PLoS One. 2011;6:e16974.
9. Hartley L, Flowers N, Holmes J, et al. Green and black tea for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2013;6:Cd009934.
10. Ried K, Sullivan TR, Fakler P, et al. Effect of cocoa on blood pressure. Cochrane Database Syst Rev. 2012;8:CD008893
11. Desideri G, Kwik-Uribe C, Grassi D, et al. Benefits in cognitive function, blood pressure, and insulin resistance through cocoa flavanol consumption in elderly subjects with mild cognitive impairment: the Cocoa, Cognition, and Aging (CoCoA) study. Hypertension. 2012;60:794-801.
12. West SG, McIntyre MD, Piotrowski MJ, et al. Effects of dark chocolate and cocoa consumption on endothelial function and arterial stiffness in overweight adults. Br J Nutr. 2014;111:653-661.
13. Hollenberg NK, Martinez G, McCullough M, et al. Aging, acculturation, salt intake, and hypertension in the Kuna of Panama. Hypertension. 1997;29:171-176.
14. Hollenberg NK, Fisher ND, McCullough ML. Flavanols, the Kuna, cocoa consumption, and nitric oxide. J Am Soc Hypertens. 2009;3:105-112.
15. McCullough ML, Chevaux K, Jackson L, et al. Hypertension, the Kuna, and the epidemiology of flavanols. J Cardiovasc Pharmacol. 2006;47 (Suppl 2):S103-S109.
16. Jauhiainen T, Korpela R. Milk peptides and blood pressure. J Nutr. 2007;137 (3 Suppl 2):825s-829s.
17. Xu JY, Qin PY, Wang LQ, et al. Effect of milk tripeptides on blood pressure: a meta-analysis of randomized controlled trials. Nutrition. 2008;24:933-940.
18. Engberink MF, Schouten EG, Kok FJ, et al. Lactotripeptides show no effect on human blood pressure: results from a double-blind randomized controlled trial. Hypertension. 2008;51:399-405.
19. Jauhiainen T, Niittynen L, Oresic M, et al. Effects of long-term intake of lactotripeptides on cardiovascular risk factors in hypertensive subjects. Eur J Clin Nutr. 2012;66:843-849.
20. Turpeinen AM, Järvenpää S, Kautiainen H, et al. Antihypertensive effects of bioactive tripeptides'a random effects meta-analysis. Ann Med. 2013;45:51-56.
21. Ralston RA, Lee JH, Truby H, et al. A systematic review and meta-analysis of elevated blood pressure and consumption of dairy foods. J Human Hypertens. 2012;26:3-13.
22. Vaskonen T. Dietary minerals and modification of cardiovascular risk factors. J Nutr Biochem. 2003;14:492-506.
23. Appel LJ, Brands MW, Daniels SR, et al. Dietary approaches to prevent and treat hypertension: a scientific statement from the American Heart Association. Hypertension. 2006;47:296-308.
24. Elwood PC, Pickering JE, Givens DI, et al. The consumption of milk and dairy foods and the incidence of vascular disease and diabetes: an overview of the evidence. Lipids. 2010;45:925-939.
25. Livingstone KM, Lovegrove JA, Cockcroft JR, et al. Does dairy food intake predict arterial stiffness and blood pressure in men? Evidence from the Caerphilly prospective study. Hypertension. 2013;61:42-47.
26. Griffith LE, Guyatt GH, Cook RJ, et al. The influence of dietary and non-dietary calcium supplementation on blood pressure: an updated meta-analysis of randomized controlled trials. Am J Hypertens. 1999;12:84-92.
27. Massey LK. Dairy food consumption, blood pressure and stroke. J Nutr. 2001;131:1875-1878.
28. Foltz M, van der Pijl PC, Duchateau GS. Current in vitro testing of bioactive peptides is not valuable. J Nutr. 2010;140:117-118.
29. Toh JY, Tan VMH, Lim PCY, et al. Flavonoids from fruit and vegetables: a focus on cardiovascular risk factors. Curr Atheroscler Rep. 2013;15:368-374.
30. Kurowska, EM, Spence JD, Jordan J, et al. HDL-cholesterol-raising effect of orange juice in subjects with hypercholesterolemia. Am J Clin Nutr. 2000;72:1095-1100.
31. Cesar TB, Aptekmann NP, Araujo MP, et al. Orange juice decreases low-density lipoprotein cholesterol in hypercholesterolemic subjects and improves lipid transfer to high-density lipoprotein in normal and hypercholesterolemic subjects. Nutr Res. 2010;30:689-694.
32. Aptekmann NP, Cesar TB. Long-term orange juice consumption is associated with low LDL-cholesterol and apolipoprotein B in normal and moderately hypercholesterolemic subjects. Lipids Health Dis. 2013;12:119.
33. Morand C, Dubray C, Milenkovic D, et al. Hesperidin contributes to the vascular protective effects of orange juice: a randomized crossover study in healthy volunteers. Am J Clin Nutr. 2011;93:73-80.
34. Simon JA, Hudes ES, Tice JA. Relation of serum ascorbic acid to mortality among US adults. J Am Coll Nutr. 2001;20:255-263.
35. Khaw KT, Bingham S, Welch A, et al. Relation between plasma ascorbic acid and mortality in men and women in EPIC-Norfolk prospective study: a prospective population study. European Prospective Investigation into Cancer and Nutrition. Lancet. 2001;357:657-663.
36. Boekholdt SM, Meuwese MC, Day NE, et al. Plasma concentrations of ascorbic acid and C-reactive protein, and risk of future coronary artery disease, in apparently healthy men and women: The EPIC-Norfolk prospective population study. Br J Nutr. 2006;96:516-522.
37. Frei B, Birlouez-Aragon I, Lykkesfeldt J. Authors perspective: what is the optimum intake of vitamin C in humans? Crit Rev Food Sci Nutrit. 2012;52:815-820.
38. Ronskley P, Brien SE, Turner BJ, et al. Association of alcohol consumption with selected CVD outcomes: a systematic review and meta-analysis. BMJ. 2011;22:342.
39. Brien SE, Ronksley PE, Turner BJ, et al. Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: systematic review and meta-analysis of interventional studies. BMJ. 2011;342.
40. Hvidtfeldt UA, Tolstrup JS, Jakobsen MU, et al. Alcohol intake and risk of coronary heart disease in younger, middle-aged, and older adults. Circulation. 2010;121: 1589-1597.
41. Xin X, He J, Frontini MG, et al. Effects of alcohol reduction on blood pressure: a meta-analysis of RCTs. Hypertension. 2001;38:1112-1117.
42. Vidavalur R, Otani H, Singal PK, et al. Significance of wine and resveratrol in cardiovascular disease: French paradox revisited. Exp Clin Cardiol. 2006;11:217-225.
43. Chiva-Blanch G, Arranz S, Lamuela-Raventos RM, et al. Effects of wine, alcohol and polyphenols on cardiovascular disease risk factors: evidences from human studies. Alcohol. 2013;48:270-277.
44. Jing Y, Han G, Hu Y, et al Tea consumption and risk of type 2 diabetes: a meta-analysis of cohort studies. J Gen Intern Med. 2009;24:557-562.
45. Woudenberg V. Tea consumption and incidence of type 2 diabetes in Europe: the EPIC-InterAct case-cohort study. PLoS One. 2012;7:e36910.
46. Grassi D, Desideri G, Necozione S, et al. Blood pressure is reduced and insulin sensitivity increased in glucose-intolerant, hypertensive subjects after 15 days of consuming high-polyphenol dark chocolate. J Nutr. 2008;138:1671-1676.
47. Muniyappa R, Hall G, Kolodziej TL, et al. Cocoa consumption for 2 wk enhances insulin-mediated vasodilatation without improving blood pressure or insulin resistance in essential hypertension. Am J Clin Nutr. 2008;88:1685-1696.
48. Timmers S, Konings E, Bilet L, et al. Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metabol. 2011;14:612-622.
49. Te Morenga L, Mallard S, Mann J. Dietary sugars and body weight: systematic review and meta-analyses of randomised controlled trials and cohort studies. BMJ. 2013;346:e7492.
50. Greenwood DC, Threapleton DE, Evans CE, et al. Association between sugar-sweetened and artificially sweetened soft drinks and type 2 diabetes: systematic review and dose-response meta-analysis of prospective studies. Br J Nutr. 2014;112:725-734.
51. Schulze MB, Manson JE, Ludwig DS, et al. Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. JAMA. 2004;292:927-934.
52. Palmer JR, Boggs DA, Krishnan S, et al. Sugar-sweetened beverages and incidence of type 2 diabetes mellitus in African American women. Arch Int Med. 2008;168:1487-1492.
53. Bhupathiraju SN, Pan A, Malik VS, et al. Caffeinated and caffeine-free beverages and risk of type 2 diabetes. Am J Clin Nutr. 2013;97:155-166.
54. The InterAct Consortium. Consumption of sweet beverages and type 2 diabetes incidence in European adults: results from EPIC-InterAct. Diabetologia. 2013;56:1520-1530.
55. Raben A, Vasilaras TH, Moller AC, et al. Sucrose compared with artificial sweeteners: different effects on ad libitum food intake and body weight after 10 wk of supplementation in overweight subjects. Am J Clin Nutrit. 2002;76:721-729.
56. Reid M, Hammersley R, Hill AJ, et al. Long-term dietary compensation for added sugar: effects of supplementary sucrose drinks over a 4-week period. Brit J Nutrit. 2007;97:193-203.
57. de Ruyter JC, Olthof MR, Seidell JC, et al. A trial of sugar-free or sugar-sweetened beverages and body weight in children. N Engl J Med. 2012;367:1397-1406.
58. Ebbeling CB, Feldman HA, Chomitz VR, et al. A randomized trial of sugar-sweetened beverages and adolescent body weight. N Engl J Med. 2012;367:1407-1416.